Clinical Trials Sponsored by Stemgen
Total 457 results
-
StemgenORION Clinical ServicesCompletedGlioblastomaNetherlands, Israel, Italy
-
StemGenexUnknownRheumatoid ArthritisUnited States
-
StemGenexUnknown
-
StemGenexUnknownChronic Obstructive Pulmonary DiseaseUnited States
-
StemGenexUnknown
-
StemGenexUnknown
-
Memgen, LLCCompleted
-
Memgen, LLCCompletedChronic Lymphocytic LeukemiaUnited States
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Ovarian Neoplasms | Endometrial Neoplasms | Carcinoma, Squamous Cell of Head and NeckUnited States, Australia, Canada
-
Seagen Inc.RecruitingColorectal Neoplasms | Pancreatic Neoplasms | Mesothelioma | Non-small Cell Lung Cancer | Cutaneous MelanomaUnited States, Canada, Switzerland, France, Germany, United Kingdom
-
Seagen Inc.RecruitingUterine Cervical Neoplasms | Stomach Neoplasms | Urinary Bladder Neoplasms | Ovarian Neoplasms | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Non-Small Cell Lung | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | HER2 Negative Breast Neoplasms and other conditionsUnited States, Spain, United Kingdom, France, Switzerland
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Seagen Inc.TerminatedUterine Cervical Neoplasms | Stomach Neoplasms | Colorectal Neoplasms | Esophageal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Pseudomyxoma Peritonei | Carcinoma, Non-Small Cell Lung | Gastroesophageal Junction Carcinoma | HER2 Negative Breast Neoplasms | Exocrine Pancreatic Adenocarcinoma | Appendiceal...United States, United Kingdom, Canada, Spain, France, Italy
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Seagen Inc.TerminatedCervical Cancer | Ovarian Cancer | Peripheral T-cell Lymphoma | Bladder Cancer | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Gastric Carcinoma | Classical Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | Cutaneous Melanoma | Gastroesophageal Junction...United States, Spain, Canada, United Kingdom, France, Italy
-
Seagen Inc.TerminatedHodgkin Lymphoma | Anaplastic Large Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Seagen Inc.CompletedHER2 Positive Metastatic Breast CancersUnited States
-
Seagen Inc.CompletedDrug-drug InteractionUnited States
-
Seagen Inc.CompletedHepatic ImpairmentUnited States
-
Seagen Inc.TerminatedLymphoma, Large B-Cell, Diffuse | Follicular Lymphoma, Grade 3b | Lymphoma, B-cell | Lymphoma, Follicular, Grade 3bUnited States
-
Seagen Inc.CompletedDrug-drug InteractionUnited States
-
Seagen Inc.TerminatedLymphoma, Large B-cell, Diffuse | Lymphoma, B-cellUnited States, Spain, Italy, Czechia, Poland
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous Leukemia | Acute Promyelocytic LeukemiaUnited States
-
Seagen Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.TerminatedLymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, HodgkinUnited States
-
Seagen Inc.CompletedAnaplastic Large-Cell LymphomaUnited States
-
Seagen Inc.TerminatedRenal Cell CarcinomaUnited States
-
Seagen Inc.CompletedProstatic NeoplasmsUnited States
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States
-
Seagen Inc.RecruitingCarcinoma, Non-Small-Cell LungUnited States, Belgium, Poland, Spain, Hungary, France
-
Seagen Inc.RecruitingMelanoma | Carcinoma, Non-Small-Cell Lung | Gastric Cancer | Ovarian Neoplasms | Squamous Cell Carcinoma of the Head and Neck | Triple Negative Breast Neoplasms | Esophageal Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, United Kingdom, France, Belgium, Germany, Netherlands
-
Seagen Inc.RecruitingAcute Myeloid Leukemia | Myelodyspastic SyndromeUnited States, Netherlands
-
Seagen Inc.Active, not recruitingPeripheral T-cell LymphomaUnited States, Czechia, Italy, Spain, United Kingdom, France
-
Seagen Inc.Terminated
-
Seagen Inc.Active, not recruitingUrologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Carcinoma, Non-Small-Cell Lung | Biliary Tract Neoplasms | HER2 Mutations Breast NeoplasmsUnited States, United Kingdom, Spain, Korea, Republic of, Italy, Belgium, Germany, Japan, Netherlands, Poland
-
Seagen Inc.Active, not recruitingGastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Korea, Republic of, United Kingdom, Taiwan, Canada, Australia
-
Seagen Inc.CompletedHER2 Positive Breast CancersUnited States, Canada
-
Seagen Inc.TerminatedMultiple MyelomaUnited States
-
Seagen Inc.TerminatedCarcinoma, Renal Cell | Breast Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Gastric Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Carcinoma, Squamous Cell of Head and Neck | Urinary Bladder NeoplasmUnited States
-
Seagen Inc.Completed
-
Seagen Inc.TerminatedDiffuse, Large B-Cell, Lymphoma | Follicular Lymphoma, Grade 3b | Transformed Lymphoma / DLBCLUnited States, Puerto Rico
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.TerminatedSystemic Lupus ErythematosusUnited States
-
Seagen Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Seagen Inc.CompletedAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States